Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | KCNJ1 | P48048 | 7/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.49 |
| ▸ | TGM2 | P21980 | 1/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16092955 | 0.83 | KCNJ1 (0.51) | MAPTKCNJ1KCNH2TGM2HRH3 | |
| SCHEMBL13527089 | 0.80 | CYP19A1 (0.54) | MAPTHRH3CYP19A1 | |
| SCHEMBL12853136 | 0.78 | MAOB (0.59) | HRH3CYP19A1MAOA | |
| SCHEMBL14568104 | 0.77 | KCNJ1 (0.41) | MAPTKCNJ1KCNH2TGM2CYP19A1 | |
| SCHEMBL16378228 | 0.74 | GUSB (0.43) | MAPTCYP19A1 | |
| SCHEMBL28945579 | 0.73 | TGM2 (0.64) | TGM2CYP19A1KMT2A | |
| SCHEMBL9969765 | 0.73 | TGM2 (0.64) | TGM2CYP19A1KMT2ATSHR | |
| SCHEMBL4829103 | 0.71 | CYP19A1 (0.57) | KCNJ1KCNH2HRH3CYP19A1KMT2A | |
| SCHEMBL16378229 | 0.70 | SLC6A2 (0.40) | MAPTCYP19A1KMT2A | |
| SCHEMBL4826108 | 0.69 | NPC1 (0.48) | MAPTKCNJ1KCNH2HRH3CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8841263-B2 | Macrocyclic compounds and methods of making and using the same | MELINTA THERAPEUTICS, INC. (US) | 2014-09-23 | — | — | US | disclosed |
| US-8841263-B2 | Macrocyclic compounds and methods of making and using the same | MELINTA THERAPEUTICS, INC. (US) | 2014-09-23 | — | — | US | disclosed |